Device Trial Radar · NCT00286286
Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.
Last checked: Nov 19, 2026Latest source record: Jan 11, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Actual
Start
Feb 2006
Primary completion
Not stated
Study completion Aug 2006
Sponsor
- Lead sponsor
- Northgate TechnologiesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 3, 2006
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effectiveness of aerosolized pain medication (.5% bupivicaine) delivered into the peritoneal cavity after laparoscopic gastric bypass surgery. This double blind study will include 50 patients. 25 will receive the aerosolized pain medication and 25 will receive a placebo (normal saline). All 50 patients will receive routine/typical methods of post-operative pain management. Post operative pain scores of the patients will be examined to determine the effect of aerosolization.
Conditions
- Pain, Postoperative
- Postoperative Pain
- Abdominal Pain
- Obesity
- Pneumoperitoneum
Interventions
Intraperitoneal Aerosolization System, IntraMystDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Baseline Pain score before surgery
- First Pain score upon arrival in PACU
- 6 hrs after first recorded pain score
2 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Alexian Brothers Medical Center
Elk Grove Village, Illinois
St. Alexius Medical Center
Hoffman Estates, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.